- Report
- May 2026
- 150 Pages
Brazil
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Indonesia
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Japan
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Malaysia
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Mexico
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Spain
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Turkey
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Australia
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Canada
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Germany
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
India
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Italy
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
China
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4489EUR$4,850USD£3,801GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4489EUR$4,850USD£3,801GBP
- Report
- September 2025
- 142 Pages
Global
From €4489EUR$4,850USD£3,801GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more